Published in Health Qual Life Outcomes on May 18, 2004
Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause (2010) 1.56
A systematic review of quality of life instruments in long-term breast cancer survivors. Health Qual Life Outcomes (2012) 1.23
Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monogr (2012) 1.21
Factors affecting quality of life in cancer patients undergoing chemotherapy. Afr Health Sci (2011) 1.15
Depressive symptoms and health-related quality of life in breast cancer survivors. J Womens Health (Larchmt) (2011) 1.13
Quality of Life in Cancer Patients undergoing Chemotherapy. Oman Med J (2009) 1.12
Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study. Health Qual Life Outcomes (2006) 1.02
Quality-of-life issues in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 1.00
Exercise, tea consumption, and depression among breast cancer survivors. J Clin Oncol (2010) 0.97
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804. Psychooncology (2008) 0.95
Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions. Dialogues Clin Neurosci (2011) 0.94
Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls. Breast Cancer Res Treat (2012) 0.93
Depression and cancer survivorship: importance of coping self-efficacy in post-treatment survivors. Psychooncology (2012) 0.92
Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol (2008) 0.92
Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol (2009) 0.88
Cancer history and other personal factors affect quality of life in patients with hepatitis C. Health Qual Life Outcomes (2005) 0.84
Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541. Cancer (2009) 0.84
A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer. J Cancer Surviv (2011) 0.82
Quality of life of Bahraini women with breast cancer: a cross sectional study. BMC Cancer (2013) 0.80
Reasons for low quality of life in South Indian cancer patient population: a prospective observational study. Indian J Pharm Sci (2014) 0.80
Determinants of Quality of Life for Breast Cancer Patients in Shanghai, China. PLoS One (2016) 0.79
Psychosocial issues in post-treatment cancer survivors: Desire for support and challenges in identifying individuals in need. J Psychosoc Oncol (2016) 0.78
Quality of life in cancer patients undergoing chemotherapy in a tertiary care center in malwa region of punjab. Indian J Palliat Care (2014) 0.78
Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors - I. Gynecol Oncol (2016) 0.78
The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up. Ann Surg Oncol (2015) 0.77
Breast cancer quality of life evaluation in Mexican Women at La Raza Hospital, Mexico City: A preliminary approach. Clinicoecon Outcomes Res (2008) 0.75
Children and Employment - Resource or Stressors after Breast Cancer? Geburtshilfe Frauenheilkd (2013) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care (1995) 10.36
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA (1998) 6.88
A chronic disease score from automated pharmacy data. J Clin Epidemiol (1992) 6.38
Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst (2002) 5.19
Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol (1998) 4.35
Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst (1995) 3.81
Quality of life of African-American and white long term breast carcinoma survivors. Cancer (1999) 2.39
Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat (1996) 2.35
The prevalence and severity of pain in cancer. Cancer (1982) 2.07
CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer (1991) 1.82
Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol (1998) 1.79
An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat (1996) 1.76
Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Cancer (2001) 1.72
Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev (1997) 1.44
Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst (2001) 1.18
The relationship among income, other socioeconomic indicators, and functional level in older persons. J Aging Health (1998) 1.16
Genetic testing for breast cancer: where are health care providers in the decision process? Genet Med (2001) 0.89
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med (2012) 4.07
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Breast cancer treatment of older women in integrated health care settings. J Clin Oncol (2006) 3.46
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42
Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol (2007) 3.06
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg (2007) 2.43
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol (2009) 2.33
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. Am J Epidemiol (2014) 2.09
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst (2007) 1.95
Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer (2007) 1.94
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol (2010) 1.94
Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer (2006) 1.92
Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev (2004) 1.82
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol (2002) 1.75
Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst (2012) 1.70
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65
Short-term (1-2 mo) hormone therapy cessation before mammography. Menopause (2009) 1.50
Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst (2013) 1.48
Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control (2008) 1.47
Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med (2010) 1.44
Chronic disease score as a predictor of hospitalization. Epidemiology (2002) 1.43
Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial. Menopause (2011) 1.40
Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr (2005) 1.39
Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas (2010) 1.38
Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study. BMC Med Res Methodol (2007) 1.36
Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst (2008) 1.35
Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control (2010) 1.33
In a randomized controlled trial, patients preferred electronic data collection of breast cancer risk-factor information in a mammography setting. J Clin Epidemiol (2005) 1.33
Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat (2007) 1.31
Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev (2007) 1.31
Screening colonoscopy in the US: attitudes and practices of primary care physicians. J Gen Intern Med (2012) 1.30
Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause (2009) 1.27
Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med (2010) 1.27
Adverse events after screening and follow-up colonoscopy. Cancer Causes Control (2011) 1.27
Using probabilistic corrections to account for abstractor agreement in medical record reviews. Am J Epidemiol (2007) 1.22
Caffeine, cajoling, and other strategies to maximize clinician survey response rates. Eval Health Prof (2002) 1.21
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol (2002) 1.19
The characteristics and training of professionals in cancer prevention and control: a survey of theAmerican Society for Preventive Oncology. Cancer Epidemiol Biomarkers Prev (2004) 1.18
Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol (2012) 1.16
Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA (2011) 1.15
Improving the concordance of mammography assessment and management recommendations. Radiology (2006) 1.15
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat (2010) 1.14
Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis (2013) 1.13
Risk factors for mortality in middle-aged women. Arch Intern Med (2006) 1.10
Early detection of breast cancer in countries with limited resources. Breast J (2003) 1.08
Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr (2005) 1.07
Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes Control (2012) 1.05
Influence of primary care use on population delivery of colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract (2012) 1.05
An assessment of the quality of mammography care at facilities treating medically vulnerable populations. Med Care (2008) 1.04
Reported mammographic density: film-screen versus digital acquisition. Radiology (2012) 1.03
Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network. Breast Cancer Res Treat (2007) 1.02
Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. J Clin Oncol (2010) 1.02
Association between time spent interpreting, level of confidence, and accuracy of screening mammography. AJR Am J Roentgenol (2012) 1.02
Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol (2012) 1.01
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat (2014) 1.01
Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history. Breast Cancer Res Treat (2008) 1.00
Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use. J Gen Intern Med (2007) 0.99
Timeliness of follow-up after abnormal screening mammogram: variability of facilities. Radiology (2011) 0.98
Survivorship research based in integrated healthcare delivery systems: the Cancer Research Network. Cancer (2008) 0.98
Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer (2011) 0.98
Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res Treat (2011) 0.98
Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof (2005) 0.98
Patient and oncologist discussions about cancer care costs. Support Care Cancer (2013) 0.98
Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms. J Am Board Fam Pract (2004) 0.97
Statin use and female reproductive organ cancer risk in a large population-based setting. Cancer Causes Control (2008) 0.96
Radiologists' attitudes and use of mammography audit reports. Acad Radiol (2010) 0.96
Varying levels of family history of breast cancer in relation to mammographic breast density (United States). Cancer Causes Control (2006) 0.95
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care (2005) 0.95
Gastric and duodenal safety of daily alendronate. Arch Intern Med (2002) 0.94
Breast cancer recurrence in older women five to ten years after diagnosis. Cancer Epidemiol Biomarkers Prev (2009) 0.94
Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. J Oncol Pract (2013) 0.93
The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol (2005) 0.93
Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. Radiology (2011) 0.93
Assessing health care use and cost consequences of a new screening modality: the case of digital mammography. Med Care (2012) 0.93
Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size. J Oncol Pract (2012) 0.93
Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer (2013) 0.92
Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Factors associated with imaging and procedural events used to detect breast cancer after screening mammography. AJR Am J Roentgenol (2007) 0.92
The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat (2011) 0.92
Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Delayed radiotherapy for breast cancer patients in integrated delivery systems. Am J Manag Care (2009) 0.92
Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res Treat (2014) 0.91
Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography. Med Care (2006) 0.90